LAUREN REISBERG: Open Payments
NPI 1124578653 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Organon LLC | 1 | $20 |
| Corium, LLC | 1 | $15 |
Products named: VRAYLAR, REXULTI, Qelbree, COBENFY, AUSTEDO XR, NEXPLANON, The Cologuard Plus Collection Kit, Azstarys.
Industry payments across IN — which companies pay providers there.
